Back
Axsome Therapeutics Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
AXSM
Axsome Therapeutics
Last Price:
$126.84
Seasonality Move:
18.58%
7 Day Trial
ALL ACCESS PASS
$
7
Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Axsome Therapeutics Stock Forecast
-
Over the next 52 weeks, Axsome Therapeutics has on average historically risen by 78.1% based on the past 9 years of stock performance.
-
Axsome Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Axsome Therapeutics Stock Undervalued?The current Axsome Therapeutics [AXSM] share price is $126.79. The Score for AXSM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
AXSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Axsome Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Axsome Therapeutics has on average historically risen by 78.1% based on the past 9 years of stock performance.
Axsome Therapeutics Stock Rating
Buy
61
Axsome Therapeutics (AXSM)
is a Buy
Is Axsome Therapeutics overpriced?
-
Axsome Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Axsome Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
axsome.com
52-Week Data
52-Week High:
139.13
52-Week Low:
64.11
Prediction Charts
Market Cap:
6.2B
Price in USD:
126.79
Volume:
789.8K
Beta:
1.61
Technical Analysis
SMA50:
113.74
SMA100:
103.29
SMA200:
94.08
52-Wk Change:
56.8%
Stock Predictions
-
Is Axsome Therapeutics stock public?Yes, Axsome Therapeutics is a publicly traded company.
-
What is the Axsome Therapeutics stock quote today?The Axsome Therapeutics stock price is 126.79 USD today.
-
How to buy Axsome Therapeutics stock online?You can buy Axsome Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-3 | 130.00 | 127.15 | 130.11 | 125.92 |
| Mar-4 | 125.84 | 125.57 | 127.22 | 122.70 |
| Mar-5 | 125.57 | 125.10 | 128.43 | 124.94 |
| Mar-6 | 123.51 | 124.41 | 126.70 | 123.35 |
| Mar-7 | 124.96 | 122.17 | 124.96 | 121.02 |
| Mar-11 | 120.00 | 119.50 | 122.00 | 117.67 |
| Mar-12 | 119.97 | 119.45 | 122.51 | 118.73 |
| Mar-13 | 119.59 | 121.65 | 122.86 | 118.10 |
| Mar-14 | 122.32 | 121.91 | 123.47 | 120.52 |
| Mar-17 | 122.68 | 125.68 | 126.94 | 121.90 |
| Mar-18 | 124.50 | 124.76 | 125.62 | 123.00 |
| Mar-19 | 124.04 | 125.90 | 126.22 | 123.51 |
| Mar-20 | 125.57 | 126.27 | 127.44 | 124.00 |
| Mar-21 | 124.75 | 126.79 | 128.50 | 124.00 |
Axsome Therapeutics Earnings
Axsome Therapeutics Earnings Report: Per Share Axsome Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Axsome Therapeutics Forecast Revenue Growth
Axsome Therapeutics Stock Analysis: Historical quarterly revenues per share for Axsome Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.64 per share, an increase next quarter of $0.20 per share, an increase this year of $1.66 per share, and an increase next year of $5.27 per share.
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.